STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[8-K] Bausch & Lomb Corp Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Bausch + Lomb furnished an update tied to its Investor Day on November 13, 2025. The company announced that the event will cover three-year financial targets, details on pipeline products, and a re-affirmation of previously announced guidance for the fiscal year ending December 31, 2025.

A press release and a slide presentation were posted to the company’s website and furnished as Exhibits 99.1 and 99.2. A webcast and replay are available on the Investor Relations section of the site. The materials are being furnished under Regulation FD and are not deemed filed or incorporated by reference.

Positive
  • None.
Negative
  • None.
false 0001860742 Bausch & Lomb Corp 0001860742 2025-11-13 2025-11-13 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

November 13, 2025

Date of Report (Date of the earliest event reported)

 

 

Bausch + Lomb Corporation

(Exact Name of Registrant as Specified in Its Charter)

 

 

Canada 001-41380 98-1613662

(State or Other Jurisdiction of

Incorporation or Organization)

(Commission

File Number)

(I.R.S. Employer

Identification Number)

 

520 Applewood Crescent

Vaughan, Ontario

Canada L4K 4B4

(Address of Principal Executive Offices)(Zip Code)

 

(905) 695-7700

(Registrant’s telephone number, including area code)

 

N/A

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Shares, No Par Value BLCO New York Stock Exchange Toronto Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

Item 7.01Regulation FD Disclosure.

 

On November 13, 2025, Bausch + Lomb Corporation (the “Company”) issued a press release announcing certain information that will be discussed during its upcoming Investor Day, to be held on November 13, 2025, including certain three-year financial targets, the details of certain pipeline products and the re-affirmation of the Company’s previously announced guidance for the fiscal year ending December 31, 2025. On November 13, 2025, the Company also posted a slide presentation to its website, which provided further details on the items to be discussed at its upcoming Investor Day. A copy of the press release is attached as Exhibit 99.1 to this report and a copy of the slide presentation is attached as Exhibit 99.2 to this report, both of which exhibits are incorporated herein by this reference. Interested persons can access the webcast, and a replay of the webcast will be available, on the Investor Relations section of the Bausch + Lomb website.

 

The information in this Item 7.01, including Exhibit 99.1 and Exhibit 99.2, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Item 7.01 and Exhibit 99.1 and Exhibit 99.2 shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.

 

Item 9.01.Financial Statements and Exhibits.

 

(d)Exhibits

 

Exhibit No.   Description

99.1*

  Press Release of Bausch + Lomb Corporation, respecting its Investor Day, dated November 13, 2025

99.2*

  Slide Presentation of Bausch + Lomb Corporation, respecting its Investor Day, dated November 13, 2025

104*

 

Cover Page Interactive Data File (formatted as Inline XBRL)

____________________________________

* Filed herewith.

 

 

 

Signatures

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  BAUSCH + LOMB CORPORATION
     
  By: /s/ Sam Eldessouky
  Name: Sam Eldessouky
  Title: Executive Vice President, Chief Financial Officer

 

Date: November 13, 2025

 

 

Bausch + Lomb Corporation

NYSE:BLCO

BLCO Rankings

BLCO Latest News

BLCO Latest SEC Filings

BLCO Stock Data

5.88B
42.03M
88.06%
11.29%
0.91%
Medical Instruments & Supplies
Ophthalmic Goods
Link
Canada
VAUGHAN